Amino acids

Kyowa Hakko USA Introduces New VELOX® Patented Performance Blend

Retrieved on: 
Wednesday, April 29, 2020
Urea cycle, Chemical compounds, Guanidines, Amino acids, Functional groups, Organic compounds, Arginine, Citrulline, Velox

NEW YORK, April 29, 2020 /PRNewswire-PRWeb/ -- Kyowa Hakko USA announces the launch of VELOX Patented Performance Blend, a clinically studied combination of Kyowa's L-Citrulline and Kyowa's L-Arginine that has been shown to increase Nitric Oxide production and to boost Nitric Oxide levels more rapidly than L-Arginine alone*.

Key Points: 
  • NEW YORK, April 29, 2020 /PRNewswire-PRWeb/ -- Kyowa Hakko USA announces the launch of VELOX Patented Performance Blend, a clinically studied combination of Kyowa's L-Citrulline and Kyowa's L-Arginine that has been shown to increase Nitric Oxide production and to boost Nitric Oxide levels more rapidly than L-Arginine alone*.
  • Media interested in setting up an interview with a Kyowa Hakko representative to discuss the VELOX Patented Performance Blend, please contact Sara White: [email protected] or 914-621.1323.
  • About VELOX Patented Performance Blend:
    VELOX Patented Performance Blend is a combination of Kyowa's L-Citrulline and Kyowa's L-Arginine.
  • VELOX Patented Performance Blend is clinically studied to rapidly increase blood Arginine levels*, increase power output*, reduce muscle soreness*, and synergistically increase blood Arginine levels*.

Gabapentin Enacarbil Market Research Report 2020 - ResearchAndMarkets.com

Retrieved on: 
Friday, April 3, 2020
Chemicals, Plastics, Manufacturing, Amino acids, Calcium channel blockers, Analgesics, Anticonvulsants, Drugs, Organ systems, Medical specialties, Prodrugs, Gabapentin enacarbil, Gabapentin, Market research

The "Gabapentin enacarbil (CAS 478296-72-9) Market Research Report 2020" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Gabapentin enacarbil (CAS 478296-72-9) Market Research Report 2020" report has been added to ResearchAndMarkets.com's offering.
  • This global report is a result of industry experts' diligent work on researching the world market of Gabapentin Enacarbil.
  • The Gabapentin enacarbil global market report key points:
    The first chapter introduces the product (composition, structure, hazards, storage, toxicological & ecological information, etc.).
  • The fifth chapter deals with Gabapentin Enacarbil market trends and forecast, distinguish Gabapentin Enacarbil manufacturers and suppliers.

2020 Analysis on the World's Gabapentin Enacarbil Industry - Trends & Developments, Major Players, Patents, and More

Retrieved on: 
Thursday, April 2, 2020
Amino acids, Calcium channel blockers, Analgesics, Anticonvulsants, Drugs, Organ systems, Medical specialties, Anxiolytics, Gabapentin, Market research

DUBLIN, April 2, 2020 /PRNewswire/ -- The "Gabapentin enacarbil (CAS 478296-72-9) Market Research Report 2020" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, April 2, 2020 /PRNewswire/ -- The "Gabapentin enacarbil (CAS 478296-72-9) Market Research Report 2020" report has been added to ResearchAndMarkets.com's offering.
  • This global report is a result of industry experts' diligent work on researching the world market of Gabapentin Enacarbil.
  • The Gabapentin enacarbil global market report key points:
    The first chapter introduces the product (composition, structure, hazards, storage, toxicological & ecological information, etc.).
  • The fifth chapter deals with Gabapentin Enacarbil market trends and forecast, distinguish Gabapentin Enacarbil manufacturers and suppliers.

Protecting a Most Precious Asset: GABA Proved to Fortify Cognitive Health in Human Trials

Retrieved on: 
Tuesday, March 31, 2020
Alternative medicine, General Health, Fitness & Nutrition, Health, Branches of biology, Neuroscience, Neurochemistry, Neurotransmitters, Amino acids, Molecular neuroscience, Biology of obsessive–compulsive disorder, gamma-Aminobutyric acid, Aminobutyric acid, gamma-Amino-beta-hydroxybutyric acid, GABBR1

They want to have agency over the state of their mental health as they age, as they do their physical health.

Key Points: 
  • They want to have agency over the state of their mental health as they age, as they do their physical health.
  • The benefits of the naturally-occurring amino acid neurotransmitter GABA [-Aminobutyric acid], found across a range of healthful foods, have never really been in doubt.
  • It has long been known that a decreased systemic level of GABA is associated with the presence of Parkinsons disease, epilepsy, Huntingtons chorea, Alzheimers disease, and schizophrenia.
  • The current studies published by Pharma Foods International offer the promise that a naturally-occurring, naturally derived supplement, GABA, may lead the way.

DGAP-News: Newly published data in Cancer Immunology, Immunotherapy support the potential of Secarna Pharmaceuticals' LNA-modified ASOs to effectively block important immunosuppressive pathway

Retrieved on: 
Thursday, March 26, 2020
Amino acids, Branches of biology, Medicine, Immune system, Indoleamine 2,3-dioxygenase, Oncology, Cancer treatments, Signal transduction, Cancer immunology, Epacadostat, Immunotherapy, MTOR, Secarna's proprietary drug discovery platform, LNAplusTM, Secarna Pharmaceuticals GmbH & Co. KG

DGAP-News: Secarna Pharmaceuticals GmbH & Co. KG / Key word(s): Scientific publication

Key Points: 
  • DGAP-News: Secarna Pharmaceuticals GmbH & Co. KG / Key word(s): Scientific publication
    Newly published data in Cancer Immunology, Immunotherapy support the potential of Secarna Pharmaceuticals' LNA-modified ASOs to effectively block important immunosuppressive pathway
    The issuer is solely responsible for the content of this announcement.
  • Both targets are catalytic enzymes that play a key role in an important immunosuppressive pathway - the degradation of tryptophan into kynurenine.
  • Secarna's approach also was shown to be synergistic with one of the clinically most advanced IDO1-specific small molecule inhibitors (epacadostat).
  • The published data show that treatment of cancer cells with LNAplusTM-modified ASOs specific for IDO1 and TDO2 lead to potent target knockdown in vitro.

Animal Feed Amino Acids Market to Reach Valuation of ~US$ 14.1 Bn by 2027; Developing Concerns About Animal Health Stimulates the Growth of Global Market, Noted TMR

Retrieved on: 
Wednesday, March 18, 2020
Amino acids, Proteinogenic amino acids, Zwitterions, Essential amino acids, Nitrogen cycle, Glucogenic amino acids, Lysine, Methionine, Protein combining

To provide precise analysis of the market, the report classifies the global animal feed amino acids market into various segments.

Key Points: 
  • To provide precise analysis of the market, the report classifies the global animal feed amino acids market into various segments.
  • Explore the latest study on global animal feed amino acids market under the title: Animal Feed Amino Acids Market (Product: Tryptophan, Lysine, Methionine, Threonine, and Others; and Application: Ruminants [Cattle, Sheep, and Others], Poultry, Swine, Pets, Equine, Aqua, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 2027 at https://www.transparencymarketresearch.com/animal-feed-amino-acids-marke...
    These insights from the report help the players to understand the factors that are actually driving the growth of global animal feed amino acids market.
  • Global Animal Feed Amino Acids Market: Regional Analysis
    Asia Pacific is expected to dominate the regional front of the global animal feed amino acids market during the tenure of 2019 to 2027.
  • The global animal feed amino acids market is segmented on the basis of:
    Animal Feed Amino Acids Market, by Product

Animal Feed Amino Acids Market to Reach Valuation of ~US$ 14.1 Bn by 2027; Developing Concerns About Animal Health Stimulates the Growth of Global Market, Noted TMR

Retrieved on: 
Wednesday, March 18, 2020
Amino acids, Proteinogenic amino acids, Zwitterions, Nitrogen cycle, Essential amino acids, Glucogenic amino acids, Lysine, Methionine, Protein combining

This demand is propelling the growth of global animal feed amino acids market

Key Points: 
  • This demand is propelling the growth of global animal feed amino acids market
    ALBANY, New York, March 18, 2020 /PRNewswire/ -- Driven by myriad of factors the global animal feed amino acids market is expected to witness a substantial growth during the tenure of 2019 to 2027, says a recent study by Transparency Market Research.
  • Explore the latest study on global animal feed amino acids market under the title: Animal Feed Amino Acids Market (Product: Tryptophan, Lysine, Methionine, Threonine, and Others; and Application: Ruminants [Cattle, Sheep, and Others], Poultry, Swine, Pets, Equine, Aqua, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 2027 at https://www.transparencymarketresearch.com/animal-feed-amino-acids-marke...
    These insights from the report help the players to understand the factors that are actually driving the growth of global animal feed amino acids market.
  • Global Animal Feed Amino Acids Market: Regional Analysis
    Asia Pacific is expected to dominate the regional front of the global animal feed amino acids market during the tenure of 2019 to 2027.
  • The global animal feed amino acids market is segmented on the basis of:
    Animal Feed Amino Acids Market, by Product

Homology Medicines Announces Peer-Reviewed Publication of HMI-102 Investigational Gene Therapy Demonstrating Restoration of Normal Metabolic Pathway in PKU Disease Model

Retrieved on: 
Monday, March 16, 2020
Amino acids, Branches of biology, Carboxylic acids, Hydroxyarenes, Metabolism, Intellectual disability, Phenylketonuria, RTT, Neurotransmitter, Metabolite, Tyrosine, 5-Hydroxyindoleacetic acid

The data also demonstrated a concomitant increase in tyrosine (Tyr), a metabolite of Phe and precursor to neurotransmitters, indicating enzymatic activity.

Key Points: 
  • The data also demonstrated a concomitant increase in tyrosine (Tyr), a metabolite of Phe and precursor to neurotransmitters, indicating enzymatic activity.
  • Additionally, brain levels of Phe, 5-HIAA (downstream serotonin metabolite) and coat color were normalized, further indicating restoration of the Phe metabolic pathway.
  • We developed a robust preclinical data package for our investigational HMI-102 gene therapy, which supported the initiation of our ongoing Phase 1/2 pheNIX clinical trial for adults with PKU, stated Albert Seymour, Ph.D., Chief Scientific Officer of Homology Medicines.
  • These published data demonstrated that a single dose of HMI-102 was able to restore the normal biochemical pathway in the established PKU model on normal protein diet.

Methionine Industry Analysis & Outlook, 2020-2025 - Market is Highly Consolidated; Top Four Players Account for >85% of the Market

Retrieved on: 
Tuesday, March 10, 2020
Amino acids, Mitsui, Evonik Industries, Methionine, Sumitomo Chemical, Sumitomo Group

Eco-friendly means of extracting methionine is projected to act as an opportunity for the market, in the future.

Key Points: 
  • Eco-friendly means of extracting methionine is projected to act as an opportunity for the market, in the future.
  • The global methionine market is highly consolidated, with the top four players accounting for more than 85% of the market.
  • Key players in the methionine market include Adisseo, Evonik Industries AG, Novus International, Sumitomo Chemical Co. Ltd., and Tokyo Chemical Industry Co. Ltd., among others.
  • By learning and communicating, Chinese and foreign companies can achieve mutual understanding, which may benefit them both in the methionine market.

No More Need for Dieting? AntiCancer’s Oral Methioninase Prevents Mouse Obesity and Diabetes on an Ultra-high-fat Diet

Retrieved on: 
Tuesday, March 10, 2020
Health, Diabetes, Other Health, Fitness & Nutrition, Research, Science, Pharmaceutical, Amino acids, Obesity, Methionine, Coronavirus, Overweight, Dieting

AntiCancer Inc. has announced that its methionine-cleaving enzyme methioninase prevented mice from becoming obese while on an ultra-high fat diet.

Key Points: 
  • AntiCancer Inc. has announced that its methionine-cleaving enzyme methioninase prevented mice from becoming obese while on an ultra-high fat diet.
  • Principal investigator Qinghong Han said, With two oral doses of methioninase per day, dieting will not be necessary in the future, as the methioninase will control excess weight gain.
  • First author Yoshihiko Tashiro said, Methioninase not only prevents obesity but obesity-related diabetes as well.
  • Methioninase is also effective against every type of cancer in mouse models and is proposed as treatment for coronavirus infection.